Alzinova: IND and FTD applications submitted
11 augusti, 10:25
Redeye comments on Alzinova’s announcement of having submitted an IND application and a Fast Track Designation request to the FDA for ALZ-101. We view this as a significant step toward initiating the planned phase II trial, marking clear progress in the regulatory process. With a CRO already in place, the focus now shifts to securing the necessary financing, preferably through a licensing agreement with a strategic partner.
Ämnen i artikeln
Alzinova: IND and FTD applications submitted
11 augusti, 10:25
Redeye comments on Alzinova’s announcement of having submitted an IND application and a Fast Track Designation request to the FDA for ALZ-101. We view this as a significant step toward initiating the planned phase II trial, marking clear progress in the regulatory process. With a CRO already in place, the focus now shifts to securing the necessary financing, preferably through a licensing agreement with a strategic partner.
Ämnen i artikeln
Börsernas utveckling
Wingefors försäljning
Börsen
Styrräntan
Aktieanalyser
Börsernas utveckling
Wingefors försäljning
Börsen
Styrräntan
Aktieanalyser
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
